UnitedHealth Group (UNH) and Amedisys (AMED) extended the deadline for closing their $3.3 billion merger agreement as the US Department of Justice scrutinizes the deal, a filing showed Friday.
Under a waiver agreement executed Thursday, the deadline is extended to 10 days after a final court decision is issued in the lawsuit filed by the Justice Department to block the proposed acquisition or on Dec. 31, 2025, whichever is earlier, the filing showed.
The new agreement includes a regulatory break fee of $275 million, which may go up to $325 million if the companies fail to divest certain assets to gain approval, according to the filing.
Amedisys' shares were up more than 3% in recent premarket activity and UnitedHealth shares were marginally advancing.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。